Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Which of the following parameters signifies the effective drug removal from the body?

Clearance. **Explanation:** **Clearance (CL)** is the most important parameter to consider when determining the efficiency of drug elimination. It is defined as the volume of plasma from which a drug is completely removed per unit of time (e.g., mL/min). Unlike the half-life, which describes the time taken for concentration to reduce by half, clearance directly signifies the body's ability to rid itself of a drug through organs like the kidneys and liver. **Analysis of Incorrect Options:** * **Bioavailability (B):** This refers to the fraction of an administered dose of unchanged drug that reaches the systemic circulation. It measures absorption and first-pass metabolism, not removal. * **Safety (C):** This is a clinical assessment of the risk-to-benefit ratio of a drug. While influenced by clearance (to avoid toxicity), it is not a pharmacokinetic parameter of drug removal. * **Volume of Distribution (Vd):** This relates the amount of drug in the body to the concentration of drug in the plasma. A high Vd indicates the drug is sequestered in tissues, which actually makes it harder to remove from the body via hemodialysis or natural clearance. **High-Yield Clinical Pearls for NEET-PG:** * **Formula:** $CL = Rate\ of\ elimination / Plasma\ concentration$. * **Steady State:** Clearance is the primary determinant of the **maintenance dose** required to achieve a target steady-state plasma concentration. * **First-order Kinetics:** In most drugs, clearance remains constant regardless of the plasma concentration. * **Zero-order Kinetics:** Clearance decreases as plasma concentration increases (e.g., Phenytoin, Alcohol, Aspirin), leading to a high risk of toxicity.

Q: Which of the following drugs is NOT metabolized by the liver?

Penicillin G. ### Explanation **Correct Option: A. Penicillin G** The primary mechanism for the elimination of **Penicillin G** is **renal excretion**, not hepatic metabolism. Approximately 90% of the drug is excreted via active tubular secretion and 10% via glomerular filtration. Because it is excreted unchanged in the urine, its half-life is significantly prolonged in patients with renal failure, necessitating dose adjustments. **Analysis of Incorrect Options:** * **B. Phenytoin:** This is a classic example of a drug metabolized by the liver via the **CYP2C9** and **CYP2C19** enzymes. It follows **zero-order kinetics** (capacity-limited metabolism) at therapeutic or high concentrations, making it a high-yield topic for exams. * **C. Erythromycin:** This macrolide antibiotic is primarily metabolized by the liver (**CYP3A4**) and excreted mainly in the bile. It is also a potent **enzyme inhibitor**, leading to numerous drug-drug interactions. * **D. Cimetidine:** An H2-receptor antagonist that undergoes significant hepatic metabolism. It is well-known in pharmacology as a broad-spectrum **cytochrome P450 inhibitor**. **High-Yield Clinical Pearls for NEET-PG:** * **Probenecid Interaction:** Probenecid inhibits the renal tubular secretion of Penicillin G, thereby increasing its plasma concentration and duration of action. * **Drugs Excreted Unchanged in Urine:** Remember the mnemonic **"GAL"** or **"KEEPS"** (Kanamycin, Ethambutol, Enalapril, Penicillin, Streptomycin). * **Hepatic vs. Renal:** Most lipid-soluble drugs require hepatic metabolism to become polar for excretion, whereas highly polar/water-soluble drugs (like Penicillins and Aminoglycosides) are often excreted unchanged by the kidneys.

Q: A drug has 40% absorption and a hepatic extraction ratio of 0.6. What is the bioavailability of this drug?

16%. ### Explanation **1. Understanding the Concept (Why A is Correct)** Bioavailability ($F$) is the fraction of an administered dose of unchanged drug that reaches the systemic circulation. When a drug is given orally, it must first be absorbed across the gut wall and then pass through the liver (first-pass metabolism) before reaching the systemic blood flow. The formula for bioavailability is: **$F = f \times (1 - ER)$** * **$f$ (Absorption):** The fraction of the dose absorbed from the gut (40% or 0.4). * **$ER$ (Extraction Ratio):** The fraction of the drug removed by the liver during its first pass. * **$(1 - ER)$:** The fraction that escapes hepatic metabolism (Hepatic Bioavailability). **Calculation:** * Absorption ($f$) = 0.4 * Extraction Ratio ($ER$) = 0.6 * Fraction escaping the liver = $1 - 0.6 = 0.4$ * **$F = 0.4 \times 0.4 = 0.16$ or 16%** **2. Analysis of Incorrect Options** * **B (24%):** This is the result of multiplying the absorption (0.4) by the extraction ratio (0.6). This represents the fraction of the dose metabolized by the liver, not the fraction that reaches the circulation. * **C (20%):** This is a distractor often chosen by students who incorrectly average the two numbers or use incorrect ratios. * **D (28%):** This value does not correlate with any standard pharmacokinetic calculation using the provided figures. **3. High-Yield Clinical Pearls for NEET-PG** * **IV Route:** By definition, the bioavailability of a drug administered intravenously is **100% ($F=1$)**. * **First-Pass Effect:** Drugs with a high hepatic extraction ratio (e.g., **Propranolol, Nitroglycerin, Lidocaine, Morphine**) have low oral bioavailability and require significantly higher oral doses compared to IV doses. * **Clinical Significance:** If a patient has liver cirrhosis, the extraction ratio decreases, leading to a potential increase in the bioavailability of high-ER drugs, necessitating dose reduction to avoid toxicity.

Q: What does a low Volume of Distribution (Vd) signify?

The drug does not accumulate significantly in tissues.. **Explanation:** **Volume of Distribution (Vd)** is a theoretical volume that relates the total amount of drug in the body to its concentration in the plasma ($Vd = \text{Total amount of drug} / \text{Plasma concentration}$) [1]. 1. **Why Option B is Correct:** A **low Vd** indicates that the drug is primarily confined to the vascular compartment (plasma) [1]. This occurs because the drug is either too large to leave the capillaries, or it is highly bound to plasma proteins (like albumin) [1]. Since the drug remains in the blood, it **does not accumulate significantly in peripheral tissues** or fat [1]. 2. **Why Other Options are Incorrect:** * **Option A:** Half-life ($t_{1/2}$) is related to both Vd and Clearance ($t_{1/2} = 0.693 \times Vd / CL$). While a low Vd *can* lead to a shorter half-life, it is not a rule; half-life depends equally on how fast the organs (liver/kidney) clear the drug. * **Option C:** Bioavailability refers to the fraction of the dose reaching systemic circulation [1]. It is independent of Vd, which describes what happens to the drug *after* it reaches the circulation. * **Option D:** This is the opposite of the truth. Drugs with low Vd usually exhibit **strong** (high) plasma protein binding, which keeps them trapped in the bloodstream [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Low Vd ( 40L):** Drugs sequestered in tissues/fat (e.g., **Chloroquine, Digoxin, Amiodarone**) [1]. * **Hemodialysis:** Drugs with a **high Vd cannot be removed by hemodialysis** because they are not present in the blood in significant amounts. * **Loading Dose:** Vd is the primary determinant used to calculate the Loading Dose ($LD = Vd \times \text{Target Plasma Concentration}$) [1].

Q: Which of the following statements regarding drug transfer across the placenta is FALSE?

Drugs most commonly transfer through active transport.. ### Explanation **1. Why Option C is the Correct (False) Statement:** The primary mechanism for drug transfer across the placenta is **simple passive diffusion**, not active transport. Most drugs cross the placental barrier based on their concentration gradient. For a drug to cross effectively via diffusion, it typically needs to be **lipophilic, non-ionized, and have a low molecular weight (<500 Daltons)** [1]. While active transport does exist in the placenta (for nutrients like amino acids and vitamins), it is not the "most common" route for drugs. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** In early pregnancy, the placental membrane is relatively thick, and surface area is small. As pregnancy progresses, the membrane thins and the surface area increases significantly, making drug transfer **greater in late pregnancy** compared to early pregnancy. * **Option B:** Most drugs cross the placenta. However, **Heparin** (large polar molecule) and **Insulin** (large polypeptide) are notable exceptions that do not cross the placental barrier in significant amounts, making them safe for use during pregnancy [1]. * **Option C:** **P-glycoprotein (P-gp)** is an efflux transporter located in the syncytiotrophoblast. It actively pumps certain xenobiotics back into the maternal circulation, acting as a protective mechanism for the fetus. **3. NEET-PG High-Yield Pearls:** * **Mnemonic for drugs that do NOT cross the placenta:** *"He Is Not Going"* (**H**eparin, **I**nsulin, **N**euromuscular blockers like d-Tubocurarine, **G**lycopyrrolate). * **Warfarin vs. Heparin:** Warfarin crosses the placenta (teratogenic); Heparin does not (safe). * **Fetal Ion Trapping:** Since fetal blood is slightly more acidic than maternal blood, basic drugs (like local anesthetics) can become ionized in the fetal circulation and get "trapped," leading to toxicity.

Q: A patient was given a 200 mg dose of a drug intravenously. If 100 mg was eliminated during the first 2 hours and the drug follows first-order elimination kinetics, how much of the drug will remain 6 hours after its administration?

25 mg. ### Explanation **1. Understanding the Correct Answer (D: 25 mg)** The core concept here is **First-Order Kinetics**, where a **constant fraction** of the drug is eliminated per unit of time. * **Initial Dose:** 200 mg. * **At 2 hours:** 100 mg was eliminated, meaning 100 mg remains. This indicates that 50% of the drug was cleared in 2 hours. Therefore, the **half-life ($t_{1/2}$)** of the drug is **2 hours**. * **At 4 hours (2nd half-life):** 50% of the remaining 100 mg is eliminated. Remaining = 50 mg. * **At 6 hours (3rd half-life):** 50% of the remaining 50 mg is eliminated. Remaining = **25 mg**. **2. Why Other Options are Incorrect** * **A (100 mg):** This is the amount remaining after only one half-life (2 hours). * **B (75 mg):** This value does not correspond to any standard half-life interval for this drug. * **C (50 mg):** This is the amount remaining after two half-lives (4 hours). If the drug followed *Zero-Order Kinetics* (constant amount eliminated), 50 mg would remain at 6 hours (50 mg lost every 2 hours), but the question specifies first-order. **3. NEET-PG Clinical Pearls & High-Yield Facts** * **First-Order Kinetics:** Most drugs follow this. Rate of elimination is directly proportional to plasma concentration. $t_{1/2}$ remains constant. * **Zero-Order Kinetics:** A constant *amount* is eliminated (e.g., **WATT**: **W**arfarin (at high doses), **A**lcohol, **T**heophylline, **T**olbutamide, **P**henytoin, **S**alicylates). $t_{1/2}$ is not constant. * **Steady State:** It takes approximately **4–5 half-lives** to reach steady-state concentration ($C_{ss}$) and the same amount of time to completely eliminate a drug from the body.

Q: Efficacy of a drug refers to:

The maximum response a drug can produce.. **Explanation:** **1. Why Option D is Correct:** **Efficacy (Intrinsic Activity)** is defined as the maximum effect ($E_{max}$) a drug can produce, regardless of the dose. It reflects the ability of a drug-receptor complex to initiate a biological response. In a graded dose-response curve, efficacy is represented by the **height (plateau)** of the curve. A drug with higher efficacy is more "effective" clinically than one with lower efficacy, even if the latter is more potent. **2. Why Other Options are Incorrect:** * **Option A:** This describes **Affinity**, which is the tendency of a drug to bind to a receptor. Affinity determines the drug's potency but not its maximum effect. * **Option B:** This describes the property of an **Agonist**. An agonist possesses both affinity (binding) and intrinsic activity (activation). * **Option C:** This describes **Potency**. Potency refers to the amount of drug (ED50) required to produce a response of a given intensity. On a dose-response curve, potency is indicated by the **left-right position** along the X-axis. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Efficacy vs. Potency:** Efficacy is clinically more important than potency. For example, Furosemide has higher efficacy than Thiazides; therefore, it is used in acute pulmonary edema where a massive response is needed. * **Full Agonist:** Has an intrinsic activity of 1. * **Antagonist:** Has affinity but **zero** intrinsic activity (efficacy = 0). * **Partial Agonist:** Has affinity but submaximal intrinsic activity (between 0 and 1). * **Inverse Agonist:** Has affinity but produces an effect opposite to that of an agonist (intrinsic activity = -1).

Question 1

Which of the following parameters signifies the effective drug removal from the body?

Accepted Answer

Clearance

Answer

Bioavailability

Answer

Safety

Answer

Volume of distribution

Question 2

Which of the following drugs exhibits zero-order kinetics?

Accepted Answer

Fomepizole

Answer

Phenytoin

Answer

Tolbutamide

Answer

Alcohol

Question 3

Which of the following drugs is NOT metabolized by the liver?

Accepted Answer

Penicillin G

Answer

Phenytoin

Answer

Erythromycin

Answer

Cimetidine

Question 4

A drug has 40% absorption and a hepatic extraction ratio of 0.6. What is the bioavailability of this drug?

Accepted Answer

16%

Answer

24%

Answer

20%

Answer

28%

Question 5

What does a low Volume of Distribution (Vd) signify?

Accepted Answer

The drug does not accumulate significantly in tissues.

Answer

The drug has a short half-life.

Answer

The drug has low bioavailability.

Answer

The drug exhibits weak plasma protein binding.

Question 6

Which of the following statements regarding drug transfer across the placenta is FALSE?

Accepted Answer

Drugs most commonly transfer through active transport.

Answer

Transfer across the placenta is lesser in early pregnancy.

Answer

Most drugs can cross the placenta to some extent, except heparin and insulin.

Answer

P-glycoprotein is present in the placenta.

Question 7

Therapeutic index of a drug is a measure of its?

Accepted Answer

Safety

Answer

Efficacy

Answer

Potency

Answer

Selectivity

Question 8

A patient was given a 200 mg dose of a drug intravenously. If 100 mg was eliminated during the first 2 hours and the drug follows first-order elimination kinetics, how much of the drug will remain 6 hours after its administration?

Accepted Answer

25 mg

Answer

100 mg

Answer

75 mg

Answer

50 mg

Question 9

Which of the following is a characteristic of a highly ionized drug?

Accepted Answer

Is excreted mainly by the kidney

Answer

Accumulates in cellular lipids

Answer

Crosses the placental barrier easily

Answer

Is well absorbed from the intestine

Question 10

Efficacy of a drug refers to:

Accepted Answer

The maximum response a drug can produce.

Answer

The affinity of the drug to bind to the receptor.

Answer

The affinity of the drug that binds to the receptor and activates it.

Answer

The dose required to produce a response.

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?